Wafik El-Deiry: Striving for impact on our community and region

Wafik El-Deiry shared a post on LinkedIn:

“Thankful to our Legorreta Cancer Center administration and leaders for all the hard work of preparation and presentations to our EAB today. Also grateful for all the feedback we received from our advisors. Our work is intensifying as we strive for impact on our community and region.”

Source: Wafik El-Deiry/LinkedIn

More posts featuring Wafik El-Deiry on oncodaily.com

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.

He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.